Logo
x

Search

Subscribe Now

All Posts by Date

PharmaShots Weekly Snapshots (August 22 - 26, 2022)

PharmaShots Weekly Snapshots (August 22 - 26, 2022)

  • August 26, 2022
Aptinyx Reports the Completion of Patient Enrollment of NYX-458 in P-II Study for Cognitive Impairment

Aptinyx Reports the Completion of Patient Enrollment of NYX-458 in P-II Study for Cognitive Impairment

  • August 26, 2022
Athos Entered into a Proteomics Research Collaboration with Caltech to Advance AI Platform for Inflammatory Bowel Disease

Athos Entered into a Proteomics Research Collaboration with Caltech to Advance AI Platform for Inflammatory Bowel Disease

  • August 26, 2022
PathAI Extends its Multi-Year Collaboration with BMS to Develop Therapies Using AI

PathAI Extends its Multi-Year Collaboration with BMS to Develop Therapies Using AI

  • August 26, 2022
TG Therapeutics Published P-III (ULTIMATE I & II) Trials Results of Ublituximab for RMS in the NEJM

TG Therapeutics Published P-III (ULTIMATE I & II) Trials Results of Ublituximab for RMS in the NEJM

  • August 26, 2022
Mycovia Reports P-III (ultraVIOLET) Study Results of Vivjoa (oteseconazole) for Recurrent Vulvovaginal Candidiasis

Mycovia Reports P-III (ultraVIOLET) Study Results of Vivjoa (oteseconazole) for Recurrent Vulvovaginal Candidiasis

  • August 26, 2022
Image

Stay Connected

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.